Group | IV-PCA | RSB | ITMB | Â |
---|---|---|---|---|
n | 30 | 30 | 30 | p |
Preoperative findings | ||||
 Age (years) | 65 (61–69) | 67 (64–72) | 65 (62–71) | 0.286 |
 Body mass index (kg/m2) | 24.4 (22.7–27.7) | 23.6 (22.2–25.2) | 24.2 (22.3–26.4) | 0.276 |
 Comorbidity | ||||
  Hypertension | 9 (30.0%) | 10 (33.3%) | 16 (53.3%) | 0.134 |
  Diabetes mellitus | 7 (23.3%) | 3 (10.0%) | 5 (16.7%) | 0.383 |
 History of abdominal surgery | 7 (23.3%) | 4 (13.3%) | 6 (20.0%) | 0.602 |
 Laboratory variables | ||||
  White blood cell count (× 109/L) | 5.4 (4.6–7.4) | 7.1 (5.9–7.6) | 6.2 (5.2–7.5) | 0.133 |
   Neutrophil (%) | 54.3 (47.9–57.2) | 55.1 (51.6–59.6) | 52.9 (51.1–54.5) | 0.118 |
   Lymphocyte (%) | 33.8 (31.3–38.3) | 32.6 (31.1–40.4) | 36.5 (34.6–39.0) | 0.089 |
  Hemoglobin (g/dL) | 14.3 (13.8–14.8) | 13.9 (13.1–15.4) | 14.7 (13.7–15.6) | 0.375 |
  Platelet count (× 109/L) | 187.0 (160.5–221.0) | 193.0 (169.8–242.0) | 207.0 (172.3–232.3) | 0.52 |
  International normalized ratio | 0.9 (0.8–0.9) | 0.9 (0.9–0.9) | 0.9 (0.8–0.9) | 0.148 |
Intraoperative findings | ||||
 Surgical duration (min) | 123 (109–145) | 123 (100–141) | 123 (114–138) | 0.713 |
 Hypotension eventa | 10 (33.3%) | 15 (50.0%) | 17 (56.7%) | 0.175 |
 Total rescue ephedrine infusion (mg) | 0 (0–4) | 2 (0–8) | 4 (0–8) | 0.139 |
 Total remifentanil infusion (mg) | 0.5 (0.4–0.6) | 0.4 (0.3–0.4)* | 0.2 (0.1–0.3)*,†| < 0.001 |
 Crystalloid fluid infusion (mL) | 500 (400–600) | 575 (400–663) | 525 (388–800) | 0.782 |
 Urine output (mL) | 100 (50–100) | 50 (50–100) | 100 (50–100) | 0.496 |
 Hemorrhage (mL) | 100 (50–100) | 100 (50–100) | 100 (50–163) | 0.405 |